Spring naar de content

Publicaties J.H.A. Vollebergh


  1. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses. van den Akker PA, Zusterzeel PL, Aalders AL, Snijders MP, Samlal RA, Vollebergh JH, Kluivers KB, Massuger LF. Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):422-5. Epub 2011 Aug 6.
  2. Factors influencing the use of frozen section analysis in adnexal masses. van den Akker PA, Kluivers KB, Aalders AL, Snijders MP, Samlal RA, Vollebergh JH, Zusterzeel PL, Massuger LF. Obstet Gynecol. 2011 Jul;118(1):57-62.
  3. Identification of barriers for good adherence to a guideline on recurrent miscarriage. Van Den Boogaard E, Hermens RP, Leschot NJ, Baron R, Vollebergh JH, Bernardus RE, Van Der Veen F, Kremer JA, Goddijn M. Acta Obstet Gynecol Scand. 2011 Feb;90(2):186-91. doi: 10.1111/j.1600-0412.2010.01000.x. Epub 2010 Dec 2.
  4. Prevalence of cysts in epithelial ovarian cancer. Kolwijck E, Lybol C, Bulten J, Vollebergh JH, Wevers RA, Massuger LF. Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):96-100. Epub 2010 Mar 29. Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses. van den Akker PA, Aalders AL, Snijders MP, Kluivers KB, Samlal RA, Vollebergh JH, Massuger LF. Gynecol Oncol. 2010 Mar;116(3):384-8. Epub 2009 Dec 2.
  5. Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses. van den Akker PA, Aalders AL, Snijders MP, Kluivers KB, Samlal RA, Vollebergh JH, Massuger LF. Gynecol Oncol. 2010 Mar;116(3):384-8. Epub 2009 Dec 2.
  6. Determinants of patients' experiences and satisfaction with fertility care. Mourad SM, Nelen WL, Akkermans RP, Vollebergh JH, Grol RP, Hermens RP, Kremer JA. Fertil Steril. 2010 Sep;94(4):1254-60. Epub 2009 Sep 3. 
  7. The Zavanelli manoeuvre in shoulder dystocia: case report and review of published cases. Vollebergh JH, van Dongen PW. Eur J Obstet Gynecol Reprod Biol. 2000 Mar;89(1):81-4. Review. 
  8. First-trimester fetal biometry using transvaginal sonography. Lasser DM, Peisner DB, Vollebergh J, Timor-Tritsch I. Ultrasound Obstet Gynecol. 1993 Mar 1;3(2):104-8.       
  9. Erythrocytic ouabain-sensitive sodium efflux rate constant in pregnancy. Didden MA, Vollebergh JH, Hoekstra MP, Schellekens A, de Jong PA. Eur J Obstet Gynecol Reprod Biol. 1993 Mar;48(3):177-81.
  10. Effects of angiotensin II on atrial natriuretic peptide in pregnancy. Didden MA, Hoekstra MP, Vollebergh JH, Schellekens A, de Jong PA. Am J Obstet Gynecol. 1991 Sep;165(3):692-5.
  11. The accuracy of ultrasonic measurement of fetal crown-rump length. Vollebergh JH, Jongsma HW, van Dongen PW. Eur J Obstet Gynecol Reprod Biol. 1989 Mar;30(3):253-6.
  12. Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study. van de Laar R1, Zusterzeel PL, Van Gorp T, Buist MR, van Driel WJ, Gaarenstroom KN, Arts HJ, van Huisseling JC, Hermans RH, Pijnenborg JM, Schutter EM, Pelikan HM, Vollebergh JH, Engelen MJ, Inthout J, Kruitwagen RF, Massuger LF. - BMC Cancer. 2014 Jan 14;14:22. doi: 10.1186/1471-2407-14-22.